InvestorsHub Logo

scottsmith

01/16/18 2:45 PM

#137600 RE: Mikesc #137598

Retail is always the last to see it. Gap will definitely fill but hopefully is bounced from there instead on heading for 2.40s.

attilathehunt

01/16/18 7:23 PM

#137683 RE: Mikesc #137598

I still haven't seen any negative news.

Three trials not starting isn’t negative? Last minute move of PD to EU when you hired a FDA guru is not negative? Stating on 12/11 trial could still start by 12/31 and over 30 days later still no “go-ahead” nod from FDA? That is negative because it implies FDA has questions/concerns for not approving Rett to move forward.

Wake up folks, we’ve been snookered.